查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1815536

2025年全球傷口護理生技藥品市場報告

Wound Care Biologics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年傷口護理生技藥品市場規模將強勁成長，到2029年將達到29億美元，複合年成長率為8.9%。預測期內的成長可歸因於對個人化醫療的關注、醫療支出的增加、基於價值的醫療模式、對先進療法日益成長的需求以及監管支持和核准。預測期內的主要趨勢包括對再生醫學、生物工程皮膚替代、創新給藥系統、慢性傷口管理的加強以及以患者為中心的護理的重視。

未來五年8.9%的預測成長率，較我們先前對該市場的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將阻礙美國燒燙傷中心的發展，因為這會增加來自瑞士和韓國的生物工程皮膚替代品和羊膜產品的成本，從而延誤慢性傷口護理，並提高傷口護理成本。由於互惠關稅以及貿易緊張局勢和限制措施的加劇對全球經濟和貿易的負面影響，其影響也將更加廣泛。

糖尿病盛行率的上升預計將在不久的將來推動傷口護理生技藥品市場的成長。糖尿病是一種血糖值升高為特徵的慢性代謝性疾病，隨著時間的推移會對心臟、血管、眼睛、腎臟和神經造成嚴重損害。生物創傷護理產品可防止過多的液體流失、熱量流失以及蛋白質和電解質的流失，同時最大限度地減少污染。它們促進自溶脫屑和顆粒狀傷口層的形成。糖尿病的高盛行率是促進傷口護理生技藥品市場成長的關鍵因素。例如，2024 年 6 月，英國政府部門國家醫療服務體系 (NHS) 報告 40 歲以下糖尿病患者數量增加，從 2022 年的 173,166 人增加到 2023 年的 216,440 人。這一顯著成長表明該年齡層出現了令人不安的趨勢，並凸顯了年輕人中糖尿病患病率的快速上升。因此，糖尿病的高盛行率正在推動傷口護理生技藥品市場的擴張。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球傷口護理生技藥品：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球傷口護理生技藥品市場：成長率分析
  • 全球傷口護理生技藥品市場表現：規模與成長，2019-2024
  • 全球傷口護理生技藥品市場預測：2024-2029年及2034年規模與成長
  • 全球傷口護理生技藥品：總目標市場（TAM）

第6章 市場細分

  • 全球傷口護理生技藥品市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 生物皮膚替代品
  • 局部藥物
  • 全球傷口護理生技藥品市場（按傷口類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
  • 潰瘍
  • 外科手術
  • 創傷
  • 燒燙傷
  • 全球傷口護理生技藥品市場（依最終使用者分類）：歷史資料及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 醫院
  • 門診手術中心（ACS）
  • 燒燙傷中心
  • 傷口診所
  • 全球傷口護理生技藥品市場：生物皮膚替代品細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 去細胞真皮基質
  • 細胞皮膚替代品
  • 複合皮膚替代品
  • 全球傷口護理生技藥品市場：按外用藥物（按類型）細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 生長因子
  • 抗菌劑
  • 酵素清創劑

第7章 區域和國家分析

  • 全球傷口護理生技藥品市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球傷口護理生技藥品市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 傷口護理生技藥品市場：競爭格局
  • 傷口護理生技藥品市場：公司簡介
    • Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Organogenesis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Smith and Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • Wright Medical Group NV Overview, Products and Services, Strategy and Financial Analysis
    • MiMedx Group Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Kerecis AG
  • Amnio Technology LLC
  • Anika Therapeutics Inc.
  • ACell Inc.
  • Derma Sciences Inc.
  • Soluble Systems Pvt. Ltd.
  • Medline Industries LP
  • Solsys Medical LLC
  • Zimmer Biomet Holdings Inc.
  • MLM Biologics Inc.
  • Tissue Genesis LLC
  • Stryker Corporation
  • Marine Polymer Technologies Inc.
  • Bioventus Inc.
  • Molnlycke Health Care AB

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年傷口護理生技藥品市場：提供新機會的國家
  • 2029年傷口護理生技藥品市場：細分領域帶來新機會
  • 2029年傷口護理生技藥品市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24609u

Wound care biologics refer to bioengineered products specifically designed for the treatment of non-healing wounds in the lower extremity. These biologics are gaining prominence in wound care due to their effective control of secretions and protective properties against bacterial infections.

The primary products within the field of wound care biologics include biologic skin substitutes and topical agents. Biologic skin substitutes play a crucial role in wound healing and have proven to be highly beneficial within the medical industry. Also known as tissue-engineered products or artificial skin, biologic skin substitutes are biological substances that facilitate wound healing by promoting the generation of new tissues. Wound care biologics are commonly utilized to treat various types of wounds, including ulcers, surgical wounds, traumatic wounds, and burns. The end users of these biologics include hospitals, Ambulatory Surgical Centers (ASCs), burn centers, and wound clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the pharmaceutical sector. Companies are grappling with higher costs on imported active pharmaceutical ingredients (APIs), glass vials, and laboratory equipment-many of which have limited alternative sources. Generic drug manufacturers, already operating with minimal profit margins, are particularly affected, with some scaling back production of low-margin medications. Biotech firms are also experiencing delays in clinical trials due to shortages of specialized reagents linked to tariffs. In response, the industry is shifting API production to regions like India and Europe, building up inventory reserves, and advocating for tariff exemptions on essential medicines.

The wound care biologics software market research report is one of a series of new reports from The Business Research Company that provides wound care biologics software market statistics, including wound care biologics software industry global market size, regional shares, competitors with a wound care biologics software market share, detailed wound care biologics software market segments, market trends and opportunities, and any further data you may need to thrive in the wound care biologics software industry. This wound care biologics software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The wound care biologics market size has grown strongly in recent years. It will grow from $1.91 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to clinical evidence and studies, regulatory framework development, wound care market evolution, limited treatment options, research and development efforts

The wound care biologics market size is expected to see strong growth in the next few years. It will grow to $2.9 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to focus on personalized medicine, rise in healthcare expenditure, value-based healthcare models, growing demand for advanced therapies, regulatory support and approvals. Major trends in the forecast period include regenerative medicine emphasis, bioengineered skin substitutes, innovative delivery systems, rise in chronic wound management, patient-centric care.

The forecast of 8.9% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. burn centers by increasing costs of bioengineered skin substitutes and amniotic membrane products sourced from Switzerland and South Korea, thereby delaying chronic wound treatments and raising advanced wound care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of diabetes is expected to drive the growth of the wound care biologics market in the near future. Diabetes is a chronic metabolic condition characterized by elevated blood glucose levels, which can lead to severe damage to the heart, blood vessels, eyes, kidneys, and nerves over time. Biological wound care products help prevent excessive water loss, heat loss, and the loss of proteins and electrolytes, while also minimizing contamination. They facilitate autolytic debridement and promote the formation of a granular wound layer. The high prevalence of diabetes is a key factor contributing to the growth of the wound care biologics market. For instance, in June 2024, the National Health Service (NHS), a UK-based government department, reported an increase in diabetes cases among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. This significant growth indicates a troubling trend in this age group and highlights the rapid rise in diabetes prevalence among younger populations. Thus, the high prevalence of diabetes is driving the expansion of the wound care biologics market.

The rising number of surgical procedures is expected to drive the growth of the wound care biologics market in the future. Surgical procedures involve medical interventions that require incisions or the use of instruments to treat a patient's medical condition. Wound care biologics typically include living cells, growth factors, or other biological materials that promote the natural healing process. As the volume of surgical procedures increases, so does the interest in advanced wound care solutions that can expedite the healing of surgical wounds, reduce complications, and improve overall patient outcomes. For example, in October 2023, the Organization for Economic Co-operation and Development, a France-based intergovernmental organization, reported an 8.4% increase in cataract surgeries in the Czech Republic, with a total of 142,670 procedures in 2022, up from 131,612 in 2021. Thus, the increase in surgical procedures is fueling the growth of the wound care biologics market.

Major companies in the wound care biologics market are concentrating on developing advanced materials, such as bioengineered, electrospun synthetic polymer matrices, to improve wound healing efficacy and support tissue regeneration. These bioengineered matrices facilitate faster wound healing and enhanced tissue regeneration by acting as scaffolds that encourage cellular migration and growth. For example, in October 2024, Royal Biologics, a US-based orthobiologics and life sciences company, introduced two innovative products at the symposium on advanced wound care: the Peak Powder Collagen Matrix, which enhances healing in various wounds by creating a gel-like barrier that supports tissue regeneration, and ElectroFiber 3D, a bioengineered matrix that promotes cellular migration and reduces healing times. These advancements significantly influence the wound care biologics market by addressing the increasing demand for effective healing solutions.

Skin graft development is a major focus for key companies in the wound care biologics market, aiming to gain a competitive edge. Skin grafting involves a surgical procedure where healthy skin is transplanted from one body area (donor site) to another area that has lost its protective covering due to injury, surgery, burns, or other traumatic conditions. For instance, in July 2022, Tides Medical, a US-based biotechnology company, launched Artacent AC, a tri-layer skin graft designed for treating complex or challenging wounds. With a three-layer structure (amnion-chorion-amnion), it surpasses traditional dual-layer products, being three times stronger and two times thicker. Artacent AC is developed to enhance handling and application to wound sites, offering clinicians an improved solution for complex patient wounds in various medical conditions such as diabetic foot ulcers, chronic wounds, burns, Mohs surgery, and other surgical applications. The product boasts a longer shelf life at room temperature, eliminating the need for refrigeration, and can be placed on either side facing the wound.

In July 2023, Coloplast, a US-based healthcare company, acquired Kerecis for $1.3 billion. Through this acquisition, Coloplast aims to strengthen its presence in the advanced wound care market by integrating Kerecis's innovative fish skin technology. This move helps Coloplast enter the high-growth U.S. biologics sector, enhance its revenue and gross margins, and raise its long-term organic growth guidance from 7% to 9% to 8% to 10%, all while allowing Kerecis to operate as a standalone business unit. Kerecis is an Iceland-based company specializing in regenerative medicine solutions using fish skin to treat chronic wounds and surgical applications.

Major companies operating in the wound care biologics market include Integra Lifesciences Corporation, Organogenesis Inc., Smith and Nephew plc, Wright Medical Group NV, MiMedx Group Inc., Kerecis AG, Amnio Technology LLC, Anika Therapeutics Inc., ACell Inc., Derma Sciences Inc., Soluble Systems Pvt. Ltd., Medline Industries LP, Solsys Medical LLC, Zimmer Biomet Holdings Inc., MLM Biologics Inc., Tissue Genesis LLC, Stryker Corporation, Marine Polymer Technologies Inc., Bioventus Inc., Molnlycke Health Care AB, Lynch Biologics LLC, Skye Biologics Holdings LLC, Osiris Therapeutics Inc., Vericel Corporation, TissueTech Inc., PolarityTE Inc., Avita Medical Limited, Celularity Inc., Human Regenerative Technologies LLC, PolyRemedy Inc.

North America was the largest region in the wound care biologics market in 2024. Asia-pacific is expected to be the fastest-growing region in the global wound care biologics market report during the forecast period. The regions covered in the wound care biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the wound care biologics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The wound care biologics market consists of revenues earned by entities by providing wound care services such as surgical and traumatic wounds, burns chronic wounds and acute Wounds. The market value includes the value of related goods sold by the service provider or included within the service offering. The wound care biologics market also includes sales of surgical equipment's, medical tape, sponges, cotton pads which are used in providing wound care biologics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wound Care Biologics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on wound care biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for wound care biologics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The wound care biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Biologic Skin Substitutes; Topical Agents
  • 2) By Wound Type: Ulcers; Surgical; Traumatic Wounds; Burns
  • 3) By End User: Hospitals; Ambulatory Surgery Center (ACS); Burn Centers; Wound Clinics
  • Subsegments:
  • 1) By Biologic Skin Substitutes: Acellular Dermal Matrices; Cellular Skin Substitutes; Composite Skin Substitutes
  • 2) By Topical Agents: Growth Factors; Antimicrobial Agents; Enzymatic Debridement Agents
  • Companies Mentioned: Integra Lifesciences Corporation; Organogenesis Inc.; Smith and Nephew plc; Wright Medical Group NV; MiMedx Group Inc.; Kerecis AG; Amnio Technology LLC; Anika Therapeutics Inc.; ACell Inc.; Derma Sciences Inc.; Soluble Systems Pvt. Ltd.; Medline Industries LP; Solsys Medical LLC; Zimmer Biomet Holdings Inc.; MLM Biologics Inc.; Tissue Genesis LLC; Stryker Corporation; Marine Polymer Technologies Inc.; Bioventus Inc.; Molnlycke Health Care AB; Lynch Biologics LLC; Skye Biologics Holdings LLC; Osiris Therapeutics Inc.; Vericel Corporation; TissueTech Inc.; PolarityTE Inc.; Avita Medical Limited; Celularity Inc.; Human Regenerative Technologies LLC; PolyRemedy Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Wound Care Biologics Market Characteristics

3. Wound Care Biologics Market Trends And Strategies

4. Wound Care Biologics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Wound Care Biologics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Wound Care Biologics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Wound Care Biologics Market Growth Rate Analysis
  • 5.4. Global Wound Care Biologics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Wound Care Biologics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Wound Care Biologics Total Addressable Market (TAM)

6. Wound Care Biologics Market Segmentation

  • 6.1. Global Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biologic Skin Substitutes
  • Topical Agents
  • 6.2. Global Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ulcers
  • Surgical
  • Traumatic Wounds
  • Burns
  • 6.3. Global Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgery Center (ACS)
  • Burn Centers
  • Wound Clinics
  • 6.4. Global Wound Care Biologics Market, Sub-Segmentation Of Biologic Skin Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Acellular Dermal Matrices
  • Cellular Skin Substitutes
  • Composite Skin Substitutes
  • 6.5. Global Wound Care Biologics Market, Sub-Segmentation Of Topical Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Growth Factors
  • Antimicrobial Agents
  • Enzymatic Debridement Agents

7. Wound Care Biologics Market Regional And Country Analysis

  • 7.1. Global Wound Care Biologics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Wound Care Biologics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Wound Care Biologics Market

  • 8.1. Asia-Pacific Wound Care Biologics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Wound Care Biologics Market

  • 9.1. China Wound Care Biologics Market Overview
  • 9.2. China Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Wound Care Biologics Market

  • 10.1. India Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Wound Care Biologics Market

  • 11.1. Japan Wound Care Biologics Market Overview
  • 11.2. Japan Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Wound Care Biologics Market

  • 12.1. Australia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Wound Care Biologics Market

  • 13.1. Indonesia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Wound Care Biologics Market

  • 14.1. South Korea Wound Care Biologics Market Overview
  • 14.2. South Korea Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Wound Care Biologics Market

  • 15.1. Western Europe Wound Care Biologics Market Overview
  • 15.2. Western Europe Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Wound Care Biologics Market

  • 16.1. UK Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Wound Care Biologics Market

  • 17.1. Germany Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Wound Care Biologics Market

  • 18.1. France Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Wound Care Biologics Market

  • 19.1. Italy Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Wound Care Biologics Market

  • 20.1. Spain Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Wound Care Biologics Market

  • 21.1. Eastern Europe Wound Care Biologics Market Overview
  • 21.2. Eastern Europe Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Wound Care Biologics Market

  • 22.1. Russia Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Wound Care Biologics Market

  • 23.1. North America Wound Care Biologics Market Overview
  • 23.2. North America Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Wound Care Biologics Market

  • 24.1. USA Wound Care Biologics Market Overview
  • 24.2. USA Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Wound Care Biologics Market

  • 25.1. Canada Wound Care Biologics Market Overview
  • 25.2. Canada Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Wound Care Biologics Market

  • 26.1. South America Wound Care Biologics Market Overview
  • 26.2. South America Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Wound Care Biologics Market

  • 27.1. Brazil Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Wound Care Biologics Market

  • 28.1. Middle East Wound Care Biologics Market Overview
  • 28.2. Middle East Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Wound Care Biologics Market

  • 29.1. Africa Wound Care Biologics Market Overview
  • 29.2. Africa Wound Care Biologics Market, Segmentation By Products, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Wound Care Biologics Market, Segmentation By Wound Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Wound Care Biologics Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Wound Care Biologics Market Competitive Landscape And Company Profiles

  • 30.1. Wound Care Biologics Market Competitive Landscape
  • 30.2. Wound Care Biologics Market Company Profiles
    • 30.2.1. Integra Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Organogenesis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Smith and Nephew plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Wright Medical Group NV Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. MiMedx Group Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Wound Care Biologics Market Other Major And Innovative Companies

  • 31.1. Kerecis AG
  • 31.2. Amnio Technology LLC
  • 31.3. Anika Therapeutics Inc.
  • 31.4. ACell Inc.
  • 31.5. Derma Sciences Inc.
  • 31.6. Soluble Systems Pvt. Ltd.
  • 31.7. Medline Industries LP
  • 31.8. Solsys Medical LLC
  • 31.9. Zimmer Biomet Holdings Inc.
  • 31.10. MLM Biologics Inc.
  • 31.11. Tissue Genesis LLC
  • 31.12. Stryker Corporation
  • 31.13. Marine Polymer Technologies Inc.
  • 31.14. Bioventus Inc.
  • 31.15. Molnlycke Health Care AB

32. Global Wound Care Biologics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Wound Care Biologics Market

34. Recent Developments In The Wound Care Biologics Market

35. Wound Care Biologics Market High Potential Countries, Segments and Strategies

  • 35.1 Wound Care Biologics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Wound Care Biologics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Wound Care Biologics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer